NYSE:BAX - Baxter International Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$72.53 +0.12 (+0.17 %)
(As of 05/27/2018 01:16 PM ET)
Previous Close$72.53
Today's Range$72.21 - $73.04
52-Week Range$56.82 - $73.04
Volume2.54 million shs
Average Volume2.88 million shs
Market Capitalization$38.84 billion
P/E Ratio29.25
Dividend Yield0.88%
Beta0.81

About Baxter International (NYSE:BAX)

Baxter International logoBaxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:BAX
CUSIP07181310
Phone224-948-2000

Debt

Debt-to-Equity Ratio0.39
Current Ratio2.63
Quick Ratio2.03

Price-To-Earnings

Trailing P/E Ratio29.25
Forward P/E Ratio25.10
P/E Growth1.87

Sales & Book Value

Annual Sales$10.56 billion
Price / Sales3.68
Cash Flow$3.9227 per share
Price / Cash18.49
Book Value$16.98 per share
Price / Book4.27

Profitability

EPS (Most Recent Fiscal Year)$2.48
Net Income$717 million
Net Margins7.75%
Return on Equity15.70%
Return on Assets8.44%

Miscellaneous

Employees47,000
Outstanding Shares535,490,000

Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, June 1st will be paid a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend is Thursday, May 31st. This is an increase from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International declared that its Board of Directors has initiated a share repurchase plan on Wednesday, February 21st 2018, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's management believes its stock is undervalued.

How were Baxter International's earnings last quarter?

Baxter International (NYSE:BAX) released its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 EPS for the quarter, topping the consensus estimate of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to the consensus estimate of $2.62 billion. Baxter International had a return on equity of 15.70% and a net margin of 7.75%. The company's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.58 earnings per share. View Baxter International's Earnings History.

When is Baxter International's next earnings date?

Baxter International is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Baxter International.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

What price target have analysts set for BAX?

16 analysts have issued 12-month price objectives for Baxter International's stock. Their predictions range from $62.00 to $83.00. On average, they expect Baxter International's share price to reach $72.7333 in the next twelve months. View Analyst Ratings for Baxter International.

Who are some of Baxter International's key competitors?

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 56)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 45)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 55)
  • Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 54)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 47)

Has Baxter International been receiving favorable news coverage?

News stories about BAX stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Baxter International earned a news impact score of 0.19 on Accern's scale. They also assigned news articles about the medical instruments supplier an impact score of 47.06 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Baxter International's major shareholders?

Baxter International's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.05%), Veritas Asset Management LLP (1.77%), Northern Trust Corp (1.65%), Wells Fargo & Company MN (1.07%), Old Mutual Global Investors UK Ltd. (0.65%) and Legal & General Group Plc (0.53%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN, Aristotle Capital Management LLC, CI Global Investments Inc., Veritas Asset Management LLP and Northern Trust Corp. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Point72 Asset Management L.P., The Manufacturers Life Insurance Company , Natixis, Old Mutual Global Investors UK Ltd., BNP Paribas Arbitrage SA, Mackay Shields LLC and Eaton Vance Management. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $72.53.

How big of a company is Baxter International?

Baxter International has a market capitalization of $38.84 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  503 (Vote Outperform)
Underperform Votes:  440 (Vote Underperform)
Total Votes:  943
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Baxter International (NYSE:BAX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Baxter International in the last 12 months. Their average twelve-month price target is $72.7333, suggesting that the stock has a possible upside of 0.28%. The high price target for BAX is $83.00 and the low price target for BAX is $62.00. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.632.692.692.54
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $72.7333$70.9286$70.9286$67.0833
Price Target Upside: 0.28% upside6.93% upside6.93% upside4.75% upside

Baxter International (NYSE:BAX) Consensus Price Target History

Price Target History for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/22/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$73.00 ➝ $83.00LowView Rating Details
5/17/2018Piper Jaffray CompaniesInitiated CoverageOverweight$77.00LowView Rating Details
4/30/2018CitigroupBoost Price TargetNeutral ➝ Neutral$70.00 ➝ $72.00MediumView Rating Details
4/30/2018Stifel NicolausBoost Price TargetHold ➝ Hold$71.00 ➝ $72.00MediumView Rating Details
2/20/2018Deutsche BankUpgradeHold ➝ Buy$80.00LowView Rating Details
2/2/2018Royal Bank of CanadaReiterated RatingHold$72.00MediumView Rating Details
2/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$73.00 ➝ $77.00MediumView Rating Details
2/2/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$74.00 ➝ $77.00MediumView Rating Details
1/3/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$73.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$71.00MediumView Rating Details
1/2/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightHighView Rating Details
10/26/2017Morgan StanleyBoost Price TargetEqual Weight$59.00 ➝ $62.00N/AView Rating Details
10/15/2017CowenSet Price TargetHold$68.00N/AView Rating Details
7/28/2017UBSBoost Price TargetNeutral$57.00 ➝ $62.00LowView Rating Details
7/27/2017Leerink SwannReiterated RatingOutperform$67.00 ➝ $75.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$70.00MediumView Rating Details
5/16/2017Goldman Sachs GroupReiterated RatingConviction-Buy$71.00HighView Rating Details
10/13/2016Wells Fargo & CoInitiated CoverageOutperformN/AView Rating Details
8/15/2016ArgusReiterated RatingHoldN/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Baxter International (NYSE:BAX) Earnings History and Estimates Chart

Earnings by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Earnings Estimates

2018 EPS Consensus Estimate: $2.80
2019 EPS Consensus Estimate: $3.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.61$0.62$0.62
Q2 20183$0.70$0.71$0.70
Q3 20183$0.72$0.74$0.73
Q4 20183$0.74$0.76$0.75
Q1 20193$0.70$0.73$0.72
Q2 20193$0.77$0.83$0.81
Q3 20192$0.81$0.85$0.83
Q4 20193$0.84$0.89$0.86

Baxter International (NYSE BAX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2018$0.70N/AView Earnings Details
4/26/2018Q1 2018$0.62$0.70$2.62 billion$2.6770 billionViewN/AView Earnings Details
2/1/2018Q4 2017$0.59$0.64$2.7652 billion$2.7740 billionViewListenView Earnings Details
10/25/2017Q3 2017$0.59$0.64$2.6634 billion$2.7070 billionViewN/AView Earnings Details
7/26/2017Q2 2017$0.57$0.63$2.5942 billion$2.6050 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.51$0.58$2.4309 billion$2.4750 billionViewN/AView Earnings Details
2/1/2017Q416$0.52$0.57$2.65 billion$2.65 billionViewListenView Earnings Details
10/25/2016Q316$0.45$0.56$2.67 billion$2.56 billionViewListenView Earnings Details
7/26/2016Q216$0.40$0.46$2.51 billion$2.60 billionViewListenView Earnings Details
4/26/2016Q116$0.29$0.36$2.35 billion$2.40 billionViewListenView Earnings Details
2/2/2016Q415$0.32$0.43$2.55 billion$2.60 billionViewListenView Earnings Details
10/27/2015Q315$0.29$0.41$2.46 billion$2.49 billionViewListenView Earnings Details
7/29/2015Q215$0.94$1.00$2.40 billion$3.90 billionViewListenView Earnings Details
4/23/2015Q115$0.88$1.00$3.70 billion$3.76 billionViewListenView Earnings Details
1/29/2015Q414$1.31$1.34$4.37 billion$4.47 billionViewListenView Earnings Details
10/16/2014Q314$1.31$1.31$4.21 billion$4.20 billionViewListenView Earnings Details
7/17/2014Q214$1.21$1.26$4.12 billion$4.30 billionViewListenView Earnings Details
4/17/2014Q114$1.10$1.19$3.88 billion$3.95 billionViewListenView Earnings Details
1/23/2014Q413$1.25$1.26$4.25 billion$4.40 billionViewListenView Earnings Details
10/17/2013Q313$1.19$1.19$3.82 billion$3.80 billionViewListenView Earnings Details
7/18/2013Q2 2013$1.13$1.16$3.70 billion$3.67 billionViewListenView Earnings Details
4/18/2013Q1 2013$1.04$1.05$3.49 billion$3.45 billionViewListenView Earnings Details
1/24/2013Q4 2012$1.26$1.26$3.72 billion$3.75 billionViewListenView Earnings Details
10/18/2012$1.14$1.14ViewN/AView Earnings Details
7/19/2012$1.11$1.12ViewN/AView Earnings Details
4/19/2012$1.00$1.01ViewN/AView Earnings Details
1/26/2012$1.17$1.17ViewN/AView Earnings Details
10/20/2011$1.08$1.09ViewN/AView Earnings Details
7/21/2011$1.02$1.07ViewN/AView Earnings Details
4/21/2011$0.93$0.98ViewN/AView Earnings Details
1/27/2011$1.10$1.11ViewN/AView Earnings Details
10/21/2010Q3 2010$0.97$1.01ViewN/AView Earnings Details
7/22/2010Q2 2010$0.92$0.93ViewN/AView Earnings Details
4/22/2010Q1 2010$0.93$0.93ViewN/AView Earnings Details
1/28/2010Q4 2009$1.03$1.03ViewN/AView Earnings Details
10/15/2009Q3 2009$0.96$0.98ViewN/AView Earnings Details
7/16/2009Q2 2009$0.94$0.96ViewN/AView Earnings Details
4/16/2009Q1 2009$0.81$0.83ViewN/AView Earnings Details
1/22/2009Q4 2008$0.89$0.91ViewN/AView Earnings Details
10/16/2008Q3 2008$0.82$0.88ViewN/AView Earnings Details
7/17/2008Q2 2008$0.81$0.85ViewN/AView Earnings Details
4/17/2008Q1 2008$0.72$0.74ViewN/AView Earnings Details
1/24/2008Q4 2007$0.74$0.76ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Baxter International (NYSE:BAX) Dividend Information

Baxter International pays an annual dividend of $0.64 per share, with a dividend yield of 0.88%. BAX's next quarterly dividend payment will be made on Monday, July 2. Baxter International pays out 25.81% of its earnings out as a dividend.
Next Dividend:7/2/2018
Annual Dividend:$0.64
Dividend Yield:0.88%
Dividend Growth:-34.00% (3 Year Average)
Payout Ratio(s):25.81% (Trailing 12 Months of Earnings)
22.15% (Based on This Year's Estimates)
19.88% (Based on Next Year's Estimates)
16.32% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2018quarterly$0.191.08%5/31/20186/1/20187/2/2018
2/20/2018Quarterly$0.160.95%3/1/20183/2/20184/2/2018
11/14/2017quarterly$0.160.99%11/30/201712/1/20171/2/2018
7/18/2017quarterly$0.161.03%8/30/20179/1/201710/2/2017
5/2/2017quarterly$0.161.14%5/31/20176/2/20177/3/2017
2/21/2017quarterly$0.131.04%3/1/20173/3/20174/3/2017
11/8/2016quarterly$0.131.12%11/30/201612/2/20161/3/2017
7/19/2016quarterly$0.131.11%8/31/20169/2/201610/3/2016
5/3/2016quarterly$0.131.15%6/1/20166/3/20167/1/2016
2/16/2016quarterly$0.11501.23%3/2/20163/4/20164/1/2016
11/11/2015quarterly$0.11501.21%12/2/201512/4/20151/4/2016
7/29/2015quarterly$0.11501.15%9/2/20159/4/201510/1/2015
5/5/2015quarterly$0.523.02%5/28/20156/1/20157/1/2015
2/17/2015quarterly$0.523.04%3/9/20153/11/20154/1/2015
11/11/2014quarterly$0.522.92%12/3/201412/5/20141/2/2015
7/22/2014quarterly$0.522.71%9/3/20149/5/201410/1/2014
5/5/2014quarterly$0.522.81%6/4/20146/6/20147/1/2014
2/18/2014quarterly$0.492.84%3/5/20143/7/20144/1/2014
11/12/2013quarterly$0.492.95%12/4/201312/6/20131/3/2014
7/23/2013quarterly$0.492.66%9/4/20139/6/201310/1/2013
5/6/2013quarterly$0.492.86%6/5/20136/7/20137/1/2013
2/19/2013quarterly$0.452.67%3/6/20133/8/20134/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Baxter International (NYSE BAX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.05%
Institutional Ownership Percentage: 83.54%
Insider Trading History for Baxter International (NYSE:BAX)
Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Baxter International (NYSE BAX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2018Brik V EyreSVPSell25,000$71.96$1,799,000.00128,777View SEC Filing  
5/22/2018Carole J ShapazianDirectorSell6,594$71.79$473,383.2616,442View SEC Filing  
5/15/2018Brik V EyreSVPSell20,000$70.57$1,411,400.0085,115View SEC Filing  
4/2/2018Peter S HellmanDirectorSell3,760$64.74$243,422.4025,522View SEC Filing  
3/28/2018James R Gavin IIIDirectorSell18,750$64.56$1,210,500.0036,398View SEC Filing  
3/2/2018Carole J ShapazianDirectorSell4,990$66.05$329,589.50View SEC Filing  
1/2/2018Giuseppe AccogliSVPSell28,641$67.00$1,918,947.00View SEC Filing  
12/4/2017Jeanne K MasonSVPSell33,350$65.25$2,176,087.50124,609View SEC Filing  
11/6/2017Third Point LlcDirectorSell5,000,000$64.23$321,150,000.00View SEC Filing  
9/5/2017Thomas T StallkampDirectorSell8,920$62.28$555,537.6016,263View SEC Filing  
8/25/2017John D ForsythDirectorSell9,440$61.76$583,014.4032,444View SEC Filing  
8/24/2017Carole J ShapazianDirectorSell4,020$61.61$247,672.2013,868View SEC Filing  
8/17/2017Giuseppe AccogliSVPSell12,670$60.96$772,363.2033,286View SEC Filing  
5/23/2017Carole J ShapazianDirectorSell2,618$57.92$151,634.569,848View SEC Filing  
5/9/2017Carole J ShapazianDirectorSell3,760$55.89$210,146.4016,226View SEC Filing  
5/8/2017Brik V EyreSVPSell130,732$55.69$7,280,465.0849,966View SEC Filing  
4/10/2017Albert P L StrouckenDirectorSell4,280$52.80$225,984.0025,667View SEC Filing  
3/29/2017James R Gavin IIIDirectorSell4,280$51.72$221,361.6034,980View SEC Filing  
2/22/2017Peter S HellmanDirectorSell4,280$49.81$213,186.8024,420View SEC Filing  
2/8/2017John D ForsythDirectorSell4,280$48.35$206,938.0031,338View SEC Filing  
5/23/2016Jose E AlmeidaCEOBuy11,691$42.75$499,790.2511,691View SEC Filing  
5/2/2016John D ForsythDirectorSell1,887$44.38$83,745.0626,320View SEC Filing  
4/4/2016John D ForsythDirectorSell1,887$41.75$78,782.2526,315View SEC Filing  
3/14/2016James R Gavin IIIDirectorSell5,660$40.34$228,324.4033,432View SEC Filing  
2/17/2016Peter S. HellmanDirectorSell5,660$38.35$217,061.0017,520View SEC Filing  
2/11/2016Kornelis J. StormDirectorSell5,660$35.98$203,646.8019,191View SEC Filing  
5/22/2015Carole J ShapazianDirectorSell1,533$67.68$103,753.44View SEC Filing  
4/27/2015James R Gavin IIIDirectorSell4,830$71.06$343,219.80View SEC Filing  
7/25/2014Carole J ShapazianDirectorSell1,645$76.98$126,632.10View SEC Filing  
7/24/2014Thomas T StallkampDirectorSell8,300$76.82$637,606.00View SEC Filing  
7/9/2014Ludwig HantsonVPSell24,693$76.00$1,876,668.00View SEC Filing  
5/2/2014Carole ShapazianDirectorSell5,680$75.28$427,590.405,146View SEC Filing  
4/23/2014Kees StormDirectorSell5,760$72.45$417,312.0015,156View SEC Filing  
4/21/2014Blake DevittDirectorSell4,334$73.12$316,902.0816,541View SEC Filing  
3/27/2014Sebastian BufalinoVPSell21,600$75.10$1,622,160.006,275View SEC Filing  
9/12/2013Carole ShapazianDirectorSell1,941$71.58$138,936.785,111View SEC Filing  
8/1/2013Robert L Parkinson JrCEOSell725,750$73.33$53,219,247.50View SEC Filing  
7/26/2013David P ScharfVPSell55,438$73.79$4,090,770.02View SEC Filing  
7/25/2013James R Gavin IIIDirectorSell5,760$72.82$419,443.20View SEC Filing  
7/24/2013Carole J ShapazianDirectorSell4,320$73.58$317,865.60View SEC Filing  
7/22/2013Robert J HombachCFOSell47,452$73.95$3,509,075.40View SEC Filing  
7/16/2013Phillip L BatchelorVPSell5,850$73.00$427,050.00View SEC Filing  
5/22/2013Blake E DevittDirectorSell1,000$72.34$72,340.00View SEC Filing  
5/20/2013Sebastian J BufalinoVPSell24,000$73.75$1,770,000.00View SEC Filing  
5/17/2013Robert M DavisVPSell130,800$73.00$9,548,400.00View SEC Filing  
9/13/2012Michael J BaughmanVPSell11,500$61.00$701,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Baxter International (NYSE BAX) News Headlines

Source:
DateHeadline
$2.85 Billion in Sales Expected for Baxter International (BAX) This Quarter$2.85 Billion in Sales Expected for Baxter International (BAX) This Quarter
www.americanbankingnews.com - May 25 at 2:00 AM
Baxter International (BAX) Receives Average Recommendation of "Buy" from AnalystsBaxter International (BAX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 24 at 10:55 AM
Zacks: Brokerages Expect Baxter International (BAX) Will Post Earnings of $0.71 Per ShareZacks: Brokerages Expect Baxter International (BAX) Will Post Earnings of $0.71 Per Share
www.americanbankingnews.com - May 23 at 9:14 PM
Baxter International (BAX) Director Sells $473,383.26 in StockBaxter International (BAX) Director Sells $473,383.26 in Stock
www.americanbankingnews.com - May 23 at 7:34 PM
Brik V. Eyre Sells 25,000 Shares of Baxter International (BAX) StockBrik V. Eyre Sells 25,000 Shares of Baxter International (BAX) Stock
www.americanbankingnews.com - May 23 at 7:16 PM
Baxter International Forecasted to Post FY2020 Earnings of $3.70 Per Share (BAX)Baxter International Forecasted to Post FY2020 Earnings of $3.70 Per Share (BAX)
www.americanbankingnews.com - May 23 at 7:52 AM
Baxter CEO Sees New Products, Expansion Driving GrowthBaxter CEO Sees New Products, Expansion Driving Growth
finance.yahoo.com - May 22 at 4:16 PM
Baxter International (BAX) Given New $83.00 Price Target at Bank of AmericaBaxter International (BAX) Given New $83.00 Price Target at Bank of America
www.americanbankingnews.com - May 22 at 2:56 PM
Baxter bullish on growth strategy, ups earnings guidanceBaxter bullish on growth strategy, ups earnings guidance
seekingalpha.com - May 21 at 4:16 PM
BRIEF-Baxter Expects Sales To Grow ~5 Pct On Compounded Annual Basis At Constant Currency Rates From 2018 To ...BRIEF-Baxter Expects Sales To Grow ~5 Pct On Compounded Annual Basis At Constant Currency Rates From 2018 To ...
www.reuters.com - May 21 at 9:45 AM
Baxter Highlights Business Strategies and Innovation at 2018 Investor ConferenceBaxter Highlights Business Strategies and Innovation at 2018 Investor Conference
finance.yahoo.com - May 21 at 9:45 AM
Piper Jaffray Companies Comments on Baxter Internationals Q2 2018 Earnings (BAX)Piper Jaffray Companies Comments on Baxter International's Q2 2018 Earnings (BAX)
www.americanbankingnews.com - May 21 at 1:09 AM
Baxter to Present at the Goldman Sachs Healthcare ConferenceBaxter to Present at the Goldman Sachs Healthcare Conference
finance.yahoo.com - May 18 at 10:59 AM
Insider Selling: Baxter International (BAX) SVP Sells 20,000 Shares of StockInsider Selling: Baxter International (BAX) SVP Sells 20,000 Shares of Stock
www.americanbankingnews.com - May 17 at 4:28 PM
Baxter Is Quickly Rebuilding Its Solid DividendBaxter Is Quickly Rebuilding Its Solid Dividend
seekingalpha.com - May 17 at 4:14 PM
Baxter International (BAX) Lifted to Buy at Zacks Investment ResearchBaxter International (BAX) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - May 17 at 3:09 PM
Reviewing Baxter International (BAX) and NovoCure (NVCR)Reviewing Baxter International (BAX) and NovoCure (NVCR)
www.americanbankingnews.com - May 17 at 1:31 PM
Baxter International (BAX) Now Covered by Analysts at Piper JaffrayBaxter International (BAX) Now Covered by Analysts at Piper Jaffray
www.americanbankingnews.com - May 17 at 10:37 AM
Baxter International (BAX) Downgraded to Hold at Zacks Investment ResearchBaxter International (BAX) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - May 16 at 1:35 PM
Baxter to Host 2018 Investor ConferenceBaxter to Host 2018 Investor Conference
finance.yahoo.com - May 15 at 4:21 PM
Baxter (BAX) Gets FDA Nod for Spectrum IQ, Secures InfusionsBaxter (BAX) Gets FDA Nod for Spectrum IQ, Secures Infusions
finance.yahoo.com - May 15 at 10:16 AM
Orthofix (OFIX) Stock Declines 13% on 18 Earnings View CutOrthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut
www.msn.com - May 14 at 4:18 PM
Orthofix (OFIX) Stock Declines 13% on '18 Earnings View CutOrthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut
finance.yahoo.com - May 14 at 4:18 PM
Baxter (BAX) Announces U.S. FDA Clearance of New Spectrum IQ Infusion SystemBaxter (BAX) Announces U.S. FDA Clearance of New Spectrum IQ Infusion System
www.streetinsider.com - May 14 at 11:03 AM
Baxter announces FDA clearance of new Spectrum IQ Infusion SystemBaxter announces FDA clearance of new Spectrum IQ Infusion System
seekingalpha.com - May 14 at 11:03 AM
Penumbra (PEN) Q1 Earnings & Revenues Top Estimates, View UpPenumbra (PEN) Q1 Earnings & Revenues Top Estimates, View Up
finance.yahoo.com - May 9 at 4:19 PM
Global Hernia Repair Devices Market Competitive landscape: Baxter International Inc, Cook Medical IncGlobal Hernia Repair Devices Market Competitive landscape: Baxter International Inc, Cook Medical Inc
www.marketwatch.com - May 9 at 9:42 AM
Amedisys (AMED) Q1 Earnings, Revenues Beat on Overall GrowthAmedisys (AMED) Q1 Earnings, Revenues Beat on Overall Growth
finance.yahoo.com - May 8 at 4:17 PM
Baxter International (BAX) to Issue Quarterly Dividend of $0.19Baxter International (BAX) to Issue Quarterly Dividend of $0.19
www.americanbankingnews.com - May 8 at 9:58 AM
BRIEF-Baxter Declares Dividend And Announces Quarterly Dividend IncreaseBRIEF-Baxter Declares Dividend And Announces Quarterly Dividend Increase
www.reuters.com - May 8 at 9:40 AM
Global Urology Devices Market Competitive landscape: Baxter International Inc, Medtronic Plc.Global Urology Devices Market Competitive landscape: Baxter International Inc, Medtronic Plc.
www.marketwatch.com - May 8 at 9:40 AM
Baxter boosts quarterly dividend by 19%, effective JulyBaxter boosts quarterly dividend by 19%, effective July
finance.yahoo.com - May 8 at 9:40 AM
Baxter Declares Dividend and Announces Quarterly Dividend IncreaseBaxter Declares Dividend and Announces Quarterly Dividend Increase
finance.yahoo.com - May 8 at 9:40 AM
Bruker (BRKR) Q1 Earnings & Revenues Beat, Margins ExpandBruker (BRKR) Q1 Earnings & Revenues Beat, Margins Expand
finance.yahoo.com - May 7 at 4:19 PM
Baxter International (BAX) Expected to Post Earnings of $0.71 Per ShareBaxter International (BAX) Expected to Post Earnings of $0.71 Per Share
www.americanbankingnews.com - May 6 at 11:22 AM
Amanda Gutiérrez Explores Lightness At The Baxter St Camera ClubAmanda Gutiérrez Explores Lightness At The Baxter St Camera Club
www.forbes.com - May 5 at 4:20 PM
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of ...Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of ...
www.businesswire.com - May 4 at 4:19 PM
IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1IDEXX Laboratories (IDXX) Earnings, Revenues Rise in Q1
finance.yahoo.com - May 4 at 4:19 PM
QIAGEN (QGEN) Beats Earnings, Revenue Estimates in Q1QIAGEN (QGEN) Beats Earnings, Revenue Estimates in Q1
finance.yahoo.com - May 4 at 4:19 PM
Becton, Dickinson (BDX) Beats on Q2 Earnings, Lifts '18 ViewBecton, Dickinson (BDX) Beats on Q2 Earnings, Lifts '18 View
finance.yahoo.com - May 3 at 4:17 PM
Hologic's (HOLX) Q2 Earnings Meet Estimates, Revenues TopHologic's (HOLX) Q2 Earnings Meet Estimates, Revenues Top
finance.yahoo.com - May 3 at 4:17 PM
Genomic Health (GHDX) Q1 Earnings Top Estimates, Margins LowGenomic Health (GHDX) Q1 Earnings Top Estimates, Margins Low
finance.yahoo.com - May 3 at 4:17 PM
Cardiovascular Systems (CSII) Q3 Earnings Top, Revenues MeetCardiovascular Systems (CSII) Q3 Earnings Top, Revenues Meet
finance.yahoo.com - May 3 at 4:17 PM
Express Scripts (ESRX) Q1 Earnings Top, Patient Claims FallExpress Scripts (ESRX) Q1 Earnings Top, Patient Claims Fall
finance.yahoo.com - May 3 at 4:17 PM
Pacific Biosciences (PACB) Loss Wider Than Expected in Q1Pacific Biosciences (PACB) Loss Wider Than Expected in Q1
finance.yahoo.com - May 3 at 4:17 PM
Cardinal Health (CAH) Misses on Q3 Earnings, Lowers '18 ViewCardinal Health (CAH) Misses on Q3 Earnings, Lowers '18 View
finance.yahoo.com - May 3 at 4:17 PM
Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney DiseaseBaxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease
finance.yahoo.com - May 2 at 9:38 AM
Ecolab (ECL) Q1 Earnings & Revenues Top, '18 Guidance SolidEcolab (ECL) Q1 Earnings & Revenues Top, '18 Guidance Solid
finance.yahoo.com - May 1 at 4:13 PM
Accuray (ARAY) Q3 Loss Wider Than Estimates, Revenues TopAccuray (ARAY) Q3 Loss Wider Than Estimates, Revenues Top
finance.yahoo.com - May 1 at 4:13 PM
3 Reasons Why You Should Invest in Baxter International Now3 Reasons Why You Should Invest in Baxter International Now
finance.yahoo.com - April 30 at 4:16 PM

SEC Filings

Baxter International (NYSE:BAX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Baxter International (NYSE:BAX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Baxter International (NYSE BAX) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.